Skip to main content
. 2023 Mar 6;75(3):735–741. doi: 10.1007/s13304-023-01474-y

Table 3.

Breast oncologic surgery procedures in the pandemic year 2020 and in the pre-pandemic year 2019 in the 3 subgroups: Lombardy; Northern Italy except Lombardy; Central and Southern Italy

Lombardy 2020 2019 p
Breast-conserving surgery 1st level oncoplasty 1406 1866  < 0.01
2nd level oncoplasty 178 142  < 0.01
Tot. 1584 (49%) 2008 (52%)  < 0.01
Mastectomy Without reconstruction 371 372  < 0.01
With immediate reconstruction Tissue expander 620 822  < 0.01
DTI 591 558  < 0.01
Flap 79 83 ns
Tot. 1661 (51%) 1835 (48%)  < 0.05
Tot. 3245 3843  < 0.01
Northern Italy except Lombardy 2020 2019 p
Breast-conserving surgery 1st level oncoplasty 1501 1809  < 0.01
2nd level oncoplasty 276 329 ns
Tot. 1777 (58%) 2138 (63%)  < 0.01
Mastectomy Without reconstruction 448 460 ns
With immediate reconstruction Tissue expander 443 482 ns
DTI 356 293  < 0.01
Flap 14 18 ns
Tot. 1261 (42%) 1253 (37%)  < 0.01
Tot. 3038 3391 ns
Central and Southern Italy 2020 2019 p
Breast-conserving surgery 1st level oncoplasty 1336 1247 ns
2nd level oncoplasty 249 297  < 0.01
Tot. 1585 (71%) 1544 (72%) ns
Mastectomy Without reconstruction 140 131 ns
With immediate reconstruction Tissue expander 129 185  < 0.01
DTI 324 254  < 0.01
Flap 48 35 ns
Tot. 641 (29%) 605 (28%) ns
Tot. 2226 2149  < 0.01

Data shown as absolute frequency. Chi-squared test for ordinal/binomial variables

DTI mastectomies with direct to implant

Bold emphasized values are statistically significant